Literature DB >> 2138104

Atrial natriuretic factor in cirrhotic patients with tense ascites. Effect of large-volume paracentesis.

F Salerno1, S Badalamenti, P Moser, E Lorenzano, P Incerti, N Dioguardi.   

Abstract

The plasma levels of atrial natriuretic factor in liver cirrhosis can be affected by various factors, such as ascites, renal function, use of diuretics drugs and dietary sodium intake. Moreover, the influence of high intra-abdominal pressure on cardiac atrial natriuretic factor release in patients with tense ascites has not been investigated. The aim of the present study was to evaluate the circulating levels of atrial natriuretic factor and their relationships to plasma renin activity, aldosterone concentration, and urinary sodium excretion in 45 cirrhotic patients divided into 4 groups: (a) cirrhotics without ascites; (b) nonazotemic cirrhotics with ascites; (c) cirrhotics with ascites and functional renal failure; and (d) cirrhotics with ascites taking diuretics. In some patients with tense ascites, atrial natriuretic factor was also measured after rapid abdominal relaxation by large volume paracentesis. Plasma levels of atrial natriuretic factor obtained in 13 healthy control subjects after 5 days on a 40-50 mEq sodium daily intake were 22.8 +/- 3.3 pg/ml. Mean plasma atrial natriuretic factor levels were normal in patients without ascites (35.1 +/- 11.4 pg/ml) and in those with ascites taking diuretics (27 +/- 9.2 pg/ml), but elevated in patients with ascites not taking diuretics (59.6 +/- 12 pg/ml) and in those with ascites and functional renal failure (58.5 +/- 16.6 pg/ml). These data show that plasma atrial natriuretic factor levels are elevated only in cirrhotic patients who are ascitic and not taking diuretics. In these patients atrial natriuretic factor levels were directly correlated with urinary sodium excretion, even though sodium balance was positive. This could be the consequence of the contrasting effects of antinatriuretic factors, as suggested by the inverse relationships between atrial natriuretic factor and urinary sodium on the one hand and plasma renin activity and plasma aldosterone concentration on the other. Twenty-six patients with tense ascites (12 taking diuretics and 14 not) were treated with rapid large-volume paracentesis (6500 +/- 330 ml of ascitic fluid removed in 168 +/- 16 min). At the end of the procedure, plasma atrial natriuretic factor levels had increased in all patients (from 45.5 +/- 10.1 to 100 +/- 17 pg/ml), whereas plasma renin activity and plasma aldosterone concentration had decreased (from 10.3 +/- 1.6 to 7 +/- 1.3 ng/ml/h, and 1160 +/- 197 to 781 +/- 155 pg/ml, respectively).(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2138104     DOI: 10.1016/0016-5085(90)90034-x

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  5 in total

Review 1.  Pathophysiology and clinical basis of prevention and treatment of complications of chronic liver disease.

Authors:  S Wagner; H U Lautz; M J Müller; F W Schmidt
Journal:  Klin Wochenschr       Date:  1991-02-06

2.  Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt.

Authors:  Massimo Cazzaniga; Francesco Salerno; Giovanni Pagnozzi; Elena Dionigi; Stefania Visentin; Ilaria Cirello; Daniele Meregaglia; Antonio Nicolini
Journal:  Gut       Date:  2006-11-29       Impact factor: 23.059

3.  Concentrated ascitic fluid reinfusion after cascade filtration in tense ascites.

Authors:  L Rossaro; A Graziotto; S Bonato; M Plebani; D H van Thiel; A Burlina; R Naccarato; M Salvagnini
Journal:  Dig Dis Sci       Date:  1993-05       Impact factor: 3.199

Review 4.  Cirrhotic cardiomyopathy.

Authors:  Luis Ruiz-del-Árbol; Regina Serradilla
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

Review 5.  Management of refractory ascites in cirrhosis: Are we out of date?

Authors:  Alagappan Annamalai; Lauren Wisdom; Megan Herada; Mazen Nourredin; Walid Ayoub; Vinay Sundaram; Andrew Klein; Nicholas Nissen
Journal:  World J Hepatol       Date:  2016-10-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.